Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms;Patogenia de la enfermedad tiroidea autoinmune: papel de los mecanismos celulares

Endocrinologia y Nutricion

Volumn 63, Issue 8, 2016, Pages 421-429

  Ramos Leví, Ana Maria ^a   Marazuela, Mónica ^a  

^a Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

Author keywords

Graves disease; Hashimoto's thyroiditis; T helper; T regulatory cells (Treg); Th17; Thyroid autoimmunity

Indexed keywords

ANTIGEN PRESENTING CELL; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; AUTOIMMUNE DISEASE; CHEMISTRY; GRAVES DISEASE; HASHIMOTO DISEASE; IMMUNOLOGY; LYMPHOCYTE; PATHOLOGY; THYROID DISEASE; THYROID GLAND;

INTERLEUKIN 17;

AUTOIMMUNE DISEASES; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-17; LYMPHOCYTES; TH17 CELLS; THYROID DISEASES; THYROID GLAND;

EID: 84971665273     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2016.04.003     Document Type: Short Survey

References (69)

1. 1 Rapoport, B., McLachlan, S.M., Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab 99 (2014), 4060–4061.
2. 2 González-Amaro, R., Marazuela, M., T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine, 52, 2015, 10.1007/s12020-015-0759-7.
3. 3 Bartalena, L., Fatourechi, V., Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest 37 (2014), 691–700.
4. 4 Weetman, A.P., Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol (Oxf) 61 (2004), 405–413.
5. 5 Lipscomb, M.F., Masten, B.J., Dendritic cells: immune regulators in health and disease. Physiol Rev 82 (2002), 97–130.
6. 6 Swiecki, M., Colonna, M., Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 234 (2010), 142–162.
7. 7 Maldonado, R.A., von Andrian, U.H., How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 108 (2010), 111–165.
8. 8 Cogni, G., Chiovato, L., An overview of the pathogenesis of thyroid autoimmunity. Hormones 12 (2013), 19–29.
9. 9 Voorby, H.A., Kabel, P.J., de Haan, M., Jeucken, P.H., van der Gaag, R.D., de Baets, M.H., et al. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol 55 (1990), 9–22.
10. 10 Lewinski, A., Sliwka, P.W., Stasiolek, M., Dendritic cells in autoimmune disorders and cancer of the thyroid. Folia Histochem Cytobiol 52 (2014), 18–28.
11. 11 Quadbeck, B., Eckstein, A.K., Tews, S., Walz, M., Hoermann, R., Mann, K., et al. Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol 55 (2002), 612–620.
12. 12 Roura-Mir, C., Catálfamo, M., Cheng, T., Marqusee, E., Besra, G.S., Jaraquemada, D., et al. CD1a and CD1c activate intrathyroidal T Cells during Graves’ disease and Hashimoto's thyroiditis. J Immunol 174 (2005), 3773–3780.
13. 13 Ruiz-Riol, M., Barnils Mdel, P., Colobran Oriol, R., Pla, A.S., Borràs Serres, F.E., Lucas-Martin, A., et al. Analysis of the cumulative changes in Graves’ disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors. J Autoimmun 36 (2011), 189–200.
14. 14 Mao, C., Wang, S., Xiao, Y., Xu, J., Jiang, Q., Jin, M., et al. Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graveś disease. J Immunol 186 (2011), 4734–4743.
15. 15 Leskela, S., Rodríguez-Muñoz, A., de la Fuente, H., Figueroa-Vega, N., Bonay, P., Martín, P., et al. Plasmacytoid dendritic cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 98 (2013), 2822–2833.
16. 16 Leskela, S., Serrano, A., de la Fuente, H., Rodríguez-Muñoz, A., Ramos-Levi, A., Sampedro-Nuñez, M., et al. Graves’ disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS ONE, 16, 2015, e0123938.
17. 17 Verginis, P., Li, H.S., Carayanniotis, G., Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+ CD25+ T cells. J Immunol 174 (2005), 7433–7439.
18. 18 Min, W.P., Zhou, D., Ichim, T.E., Strejan, G.H., Xia, X., Yang, J., et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 170 (2003), 1304–1312.
19. 19 Horwitz, D.A., Zheng, S.G., Natural Gray, J.D., TGF-B-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 29 (2008), 429–435.
20. 20 Pujol-Borrell, R., Hanafusa, T., Chiovato, L., Bottazzo, G.F., Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature 304 (1983), 71–73.
21. 21 Marazuela, M., Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur J Endocrinol 140 (1999), 287–290.
22. 22 Marazuela, M., Sanchez-Madrid, F., Acevedo, A., Larranaga, E., de Landazuri, M.O., Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders. Clin Exp Immunol 102 (1995), 328–334.
23. 23 García-López, M.A., Sancho, D., Sánchez-Madrid, F., Marazuela, M., Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86 (2001), 5008–5016.
24. 24 Antonelli, A., Ferrari, S.M., Corrado, A., Di Domenicantonio, A., Fallahi, P., Autoimmune thyroid disorders. Autoimmun Rev 14 (2015), 174–180.
25. 25 Iitaka, M., Miura, S., Yamanaka, K., Kawasaki, S., Kitahama, S., Kawakami, Y., et al. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves’ disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 83 (1998), 3908–3912.
26. 26 Figueroa-Vega, N., Alfonso-Pérez, M., Cuesta-Mateos, C., Sánchez-Madrid, F., Moreno-Otero, R., González-Amaro, R., et al. Tie-2 is overexpressed by monocytes in autoimmune thyroid disorders and participates in their recruitment to the thyroid gland. J Clin Endocrinol Metab 94 (2009), 2626–2633.
27. 27 Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B., Roliński, J., Immune disorders in Hashimoto's thyroiditis: what do we know so far?. J Immunol Res, 2015, 2015, 979167.
28. 28 Nagayama, Y., Graves’ animal models of Graves’ hyperthyroidism. Thyroid 17 (2007), 981–988.
29. 29 Salvi, M., Immunotherapy for Graves’ ophtalmopathy. Curr Opin Endocrinol Diabetes Obes 21 (2014), 409–414.
30. 30 Kristensen, B., Hegedüs, L., Lundy, S.K., Brimnes, M.K., Smith, T.J., Nielsen, C.H., Characterization of regulatory B cells in Graves’ disease and Hashimoto's thyroiditis. PLoS ONE, 10, 2015, e0127949.
31. 31 Eshaghkhani, Y., Sanati, M.H., Nakhjavani, M., Safari, R., Khajavi, A., Ataei, M., et al. Disturbed Th1 and Th2 balance in patients with Graves’ disease. Minerva Endocrinol 41 (2016), 28–36.
32. 32 Weetman, A.P., Yateman, M.E., Ealey, P.A., Black, C.M., Reimer, C.B., Williams, R.C. Jr., et al. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86 (1990), 723–727.
33. 33 Evans, M., Sanders, J., Tagami, T., Sanders, P., Young, S., Roberts, E., et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol (Oxf) 73 (2010), 404–412.
34. 34 Latrofa, F., Chazenbalk, G.D., Pichurin, P., Chen, C.R., McLachlan, S.M., Rapoport, B., Affinity-enrichment of thyrotropin receptor autoantibodies from Graves’ patients and normal individuals provides insight into their properties and possible origin from natural antibodies. J Clin Endocrinol Metab 89 (2004), 4734–4745.
35. 35 Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Regulatory T cells: how do they suppress immune responses?. Int Immunol 21 (2009), 1105–1111.
36. 36 Wang, S.H., Chen, G.H., Fan, Y., Van Antwerp, M., Baker, J.R., Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by expansion of CD4+ CD25+ regulatory T cells. Endocrinology 150 (2009), 2000–2007.
37. 37 Gambineri, E., Torgerson, T.R., Ochs, H.D., Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of Foxp3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15 (2003), 430–435.
38. 38 Marazuela, M., García-López, M.A., Figueroa-Vega, N., de la Fuente, H., Alvarado-Sánchez, B., Monsiváis-Urenda, A., et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91 (2006), 3639–3646.
39. 39 Nakahara, M., Nagayama, Y., Ichikawa, T., Yu, L., Eisenbarth, G.S., Abiru, N., The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in non-obese diabetic mice at different ages. Autoimmunity 44 (2011), 504–510.
40. 40 Pan, D., Shin, Y.H., Gopalakrishnan, G., Hennessey, J., De Groot, L.J., Regulatory T cells in Graves’ disease. Clin Endocrinol 71 (2009), 587–593.
41. 41 Glick, A.B., Wodzinski, A., Fu, P., Levine, A.D., Wald, D.N., Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 23 (2013), 871–878.
42. 42 Bossowski, A., Moniuszko, M., Dabrowska, M., Sawicka, B., Rusak, M., Jeznach, M., et al. A lower proportions of CD4+CD25 high and CD4+ Foxp3+, but not CD4+ CD25+ CD127lowFoxp3+ T cell levels in children with autoimmune thyroid diseases. Autoimmune 46 (2013), 222–230.
43. 43 Doníz-Padilla, L., Paniagua, A.E., Sandoval-Correa, P., Monsiváis-Urenda, A., Leskela, S., Marazuela, M., et al. Analysis of expression and function of the inhibitory receptor ILT2 in lymphocytes from patients with autoimmune thyroid disease. Eur J Endocrinol 165 (2011), 129–136.
44. 44 Rodríguez-Muñoz, A., Vitales-Noyola, M., Ramos-Levi, A., Serrano-Somavilla, A., González-Amaro, R., Marazuela, M., Levels of regulatory T cells CD69+NKG2D +IL-10+ are increased in patients with autoimmune thyroid disorders. Endocrine 51 (2016), 478–489.
45. 45 Unutmaz, D., RORC2: the master of human Th17 cell programming. Eur J Immunol 39 (2009), 1452–1455.
46. 46 Crome, S.Q., Wang, A.Y., Kang, C.Y., Levings, M.K., The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. Eur J Immunol 39 (2009), 1480–1493.
47. 47 Wilson, N.J., Boniface, K., Chan, J.R., McKenzie, B.S., Blumenschein, W.M., Mattson, J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007), 903–905.
48. 48 Song, X., Gao, H., Qian, Y., Th17 differentiation and their pro-inflammation function. Adv Exp Med Biol 841 (2014), 99–151.
49. 49 Basdeo, S.A., Moran, B., Cluxton, D., Canavan, M., McCormick, J., Connolly, M., et al. Polyfunctional, pathogenic cd161+ th17 lineage cells are resistant to regulatory T cell-mediated suppression in the context of autoimmunity. J Immunol 195 (2015), 528–540.
50. 50 Ghoreschi, K., Laurence, A., Yang, X.P., Tato, C.M., McGeachy, M.J., Konkel, J.E., et al. Generation of pathogenic Th17 cells in the absence of TGF-β signalling. Nature 467 (2010), 967–971.
51. 51 Langrish, C.L., Chen, Y., Blumenschein, W.M., Mattson, J., Basham, B., Sedgwick, J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005), 233–240.
52. 52 Ghoreschi, K., Laurence, A., Yang, X.P., Hirahara, K., O'Shea, J.J., T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol 32 (2011), 395–401.
53. 53 Lee, Y., Awasthi, A., Yosef, N., Quintana, F.J., Xiao, S., Peters, A., et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13 (2012), 991–999.
54. 54 Nakae, S., Iwakura, Y., Suto, H., Galli, S.J., Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 81 (2007), 1258–1268.
55. 55 Li, M.O., Wan, Y.Y., Flavell, R.A., T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26 (2007), 579–591.
56. 56 Sakaguchi, S., Vignali, D.A., Rudensky, A.Y., Niec, R.E., Waldman, H., The plasticity and stability of regulatory T cells. Nat Rev Immunol 13 (2013), 461–467.
57. 57 Lee, Y.K., Mukasa, R., Hatton, R.D., Weaver, C.T., Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 21 (2009), 274–280.
58. 58 Pandiyan, P., Zhu, J., Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine 76 (2015), 13–24.
59. 59 Shi, L., Bi, M., Yang, R., Zhou, J., Zhao, S., Fan, C., et al. Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice. J Endocrinol Invest 37 (2014), 43–50.
60. 60 Figueroa-Vega, N., Alfonso-Pérez, M., Benedicto, I., Sánchez-Madrid, F., González-Amaro, R., Marazuela, M., Increased circulating proinflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 95 (2010), 953–962.
61. 61 Qin, Q., Liu, P., Liu, L., Wang, R., Yan, N., Yang, J., et al. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves’ disease. Braz J Med Biol Res 45 (2012), 1202–1208.
62. 62 Peng, D., Xu, B., Wang, Y., Guo, H., Jiang, Y., A high frequency of circulating th22 and th17 cells in patients with new onset Graves’ disease. PLoS ONE, 8, 2013, e68446.
63. 63 Li, D., Cai, W., Gu, R., Zhang, Y., Zhang, H., Tang, K., et al. Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients. Clin Immunol 149 (2013), 411–420.
64. 64 Guo, H., Peng, D., Yang, X.G., Wang, Y., Xu, B.C., Ni, J.S., et al. A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis. PLoS ONE, 9, 2014, e84545.
65. 65 Xue, H., Yu, X., Ma, L., Song, S., Li, Y., Zhang, L., et al. The possible role of CD4(+)CD25(high)Foxp3(+)/CD4(+)IL-17A(+) cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine 50 (2015), 665–673.
66. 66 Rodríguez-Muñoz, A., Martínez-Hernández, R., Ramos-Leví, A.M., Serrano-Somavilla, A., González-Amaro, R., Sánchez-Madrid, F., et al. Circulating microvesicles regulate Treg and Th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metab 100 (2015), E1531–E1539.
67. 67 Wang, S., Baidoo, S.E., Liu, Y., Zhu, C., Tian, J., Ma, J., et al. T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis. Clin Exp Immunol 171 (2013), 63–68.
68. 68 Liu, Y., Tang, X., Tian, J., Zhu, C., Peng, H., Rui, K., et al. Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto's thyroiditis. Int J Mol Sci 15 (2014), 21674–21686.
69. 69 Pérez-Moreiras, J.V., Alvarez-López, A., Gómez, E.C., Treatment of active corticosteroid-resistant Graves’ orbitopathy. Ophthal Plast Reconstr Surg 30 (2014), 162–167.